Co-Authors
This is a "connection" page, showing publications co-authored by Yingmei Feng and Ronghua Jin.
Connection Strength
1.584
-
Quantification of SARS-CoV-2 antigen levels in the blood of patients with COVID-19. Sci China Life Sci. 2021 07; 64(7):1193-1196.
Score: 0.229
-
Lower Circulating Interferon-Gamma Is a Risk Factor for Lung Fibrosis in COVID-19 Patients. Front Immunol. 2020; 11:585647.
Score: 0.226
-
Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019. J Infect Dis. 2020 06 16; 222(1):34-37.
Score: 0.222
-
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines. Cell Res. 2021 07; 31(7):732-741.
Score: 0.059
-
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development. Signal Transduct Target Ther. 2021 03 27; 6(1):134.
Score: 0.059
-
Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China. Front Immunol. 2021; 12:614436.
Score: 0.058
-
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021 04 01; 184(7):1895-1913.e19.
Score: 0.058
-
Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial. Respiration. 2021; 100(2):116-126.
Score: 0.058
-
Early Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies as a Serologic Marker of Infection in Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2066-2072.
Score: 0.057
-
Downregulated Gene Expression Spectrum and Immune Responses Changed During the Disease Progression in Patients With COVID-19. Clin Infect Dis. 2020 11 19; 71(16):2052-2060.
Score: 0.057
-
Immune suppression in the early stage of COVID-19 disease. Nat Commun. 2020 11 17; 11(1):5859.
Score: 0.057
-
Comparison of qualitative and quantitative analyses of COVID-19 clinical samples. Clin Chim Acta. 2020 Nov; 510:613-616.
Score: 0.056
-
Preliminary Exploration of the Cause of Liver Disorders During Early Stages in COVID-19 Patients. Front Med (Lausanne). 2020; 7:501.
Score: 0.056
-
Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. 2020 07 09; 5(13).
Score: 0.056
-
The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia. Cell Death Dis. 2020 06 08; 11(6):429.
Score: 0.055
-
A Novel Scoring System for Prediction of Disease Severity in COVID-19. Front Cell Infect Microbiol. 2020; 10:318.
Score: 0.055
-
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. Cell. 2020 07 09; 182(1):73-84.e16.
Score: 0.055
-
High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients. Cell Mol Immunol. 2020 06; 17(6):650-652.
Score: 0.055
-
Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020 Apr; 11(2):216-228.
Score: 0.054